179 related articles for article (PubMed ID: 4048971)
1. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
Myers CE
Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological bases of intraperitoneal chemotherapy].
Gladieff L; Chatelut E; Dalenc F; Ferron G
Bull Cancer; 2009 Dec; 96(12):1235-42. PubMed ID: 19923051
[TBL] [Abstract][Full Text] [Related]
4. [The value of a Tenckhoff catheter in ovarian cancer].
Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.
de Bree E; Theodoropoulos PA; Rosing H; Michalakis J; Romanos J; Beijnen JH; Tsiftsis DD
Cancer Treat Rev; 2006 Oct; 32(6):471-82. PubMed ID: 16942841
[TBL] [Abstract][Full Text] [Related]
7. Complications associated with intraperitoneal chemotherapy catheters.
Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
Tummala MK; Alagarsamy S; McGuire WP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
Walker JL; Armstrong DK; Huang HQ; Fowler J; Webster K; Burger RA; Clarke-Pearson D
Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
[TBL] [Abstract][Full Text] [Related]
10. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chemotherapy: the use of concurrent systemic neutralizing agents.
Howell SB
Semin Oncol; 1985 Sep; 12(3 Suppl 4):17-22. PubMed ID: 3876602
[TBL] [Abstract][Full Text] [Related]
12. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal chemotherapy for ovarian carcinoma.
Markman M
Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy in the management of colon cancer.
Markman M
Semin Oncol; 1999 Oct; 26(5):536-9. PubMed ID: 10528901
[TBL] [Abstract][Full Text] [Related]
15. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.
Jenkins J; Sugarbaker PH; Gianola FJ; Myers CE
Surg Gynecol Obstet; 1982 Jun; 154(6):858-62. PubMed ID: 7079929
[TBL] [Abstract][Full Text] [Related]
16. [Intraperitoneal chemotherapy in ovarian carcinoma].
Piura B
Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
[TBL] [Abstract][Full Text] [Related]
18. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
[No Abstract] [Full Text] [Related]
19. Intraperitoneal therapy in the management of patients with ovarian cancer.
McClay EF; Howell SB
Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
[TBL] [Abstract][Full Text] [Related]
20. [Importance and problems of intraperitoneal chemotherapy].
Jakesz R
Wien Med Wochenschr; 1990 Apr; 140(8):199-202. PubMed ID: 2194375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
